Literature DB >> 1659588

Multiple sclerosis patients have reduced HLA class II-restricted cytotoxic responses specific for both measles and herpes virus.

S M de Silva1, H F McFarland.   

Abstract

It has been previously demonstrated that the generation of measles virus (MV)-specific cytotoxicity (CTL) is reduced in patients with multiple sclerosis (MS). By contrast, CTL specific for influenza virus (FLU) and mumps virus is normal. It is uncertain if reduced CTL is limited to MV in MS patients, or if reduced CTL may be found to other viruses as well. Since MV-specific CTL is predominantly restricted by HLA class II molecules, while FLU-specific and mumps-specific CTL have large HLA class I-restricted components, reduced MV-specific CTL may reflect a broader reduction in HLA class II-restricted CTL in patients with MS. To examine this question we studied the generation of CTL specific for herpes simplex virus type I (HSV). HSV-specific CTL, like MV-specific CTL is predominantly restricted by HLA class II molecules. We found that patients with MS had reduced generation of CTL to both MV and HSV. Most, but not all patients who had reduced generation of CTL to one virus also had a similar impairment with respect to the second virus. Some patients, however, had a reduction in the generation of CTL only to MV or to HSV. These findings extend our earlier observations regarding reduced MV-specific CTL in patients with MS to a second HLA class II-restricted virus, HSV. Such a reduction may reflect discrete impairments in immune function to separate viruses, possibly those that are associated with viral persistence, or may reflect a more generalized defect in HLA class II-restricted CTL.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659588      PMCID: PMC7119527          DOI: 10.1016/0165-5728(91)90176-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  29 in total

Review 1.  Immunoregulatory function of human autoreactive T-cell lines and clones.

Authors:  W Strober; S P James
Journal:  Immunol Rev       Date:  1990-08       Impact factor: 12.988

2.  Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls.

Authors:  S Baig; O Olsson; T Olsson; A Löve; S Jeansson; H Link
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group.

Authors: 
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

4.  Virus-specific cytotoxic T cells in multiple sclerosis.

Authors:  H F McFarland; A Goodman; S Jacobson
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Recognition of influenza virus-infected B-cell lines by human influenza virus-specific CTL.

Authors:  F T Rotteveel; E Braakman; B Robbe; C J Lucas
Journal:  Cell Immunol       Date:  1988-02       Impact factor: 4.868

Review 6.  Detection by hybridization of viral infection of the human central nervous system.

Authors:  A T Haase; L Stowring; P Ventura; J Burks; G Ebers; W Tourtellotte; K Warren
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

7.  Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases.

Authors:  E Gleichmann; S T Pals; A G Rolink; T Radaszkiewicz; H Gleichmann
Journal:  Immunol Today       Date:  1984-11

8.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

9.  Functional heterogeneity of L3T4+ T cells in MRL-lpr/lpr mice. L3T4+ T cells suppress major histocompatibility complex-self-restricted L3T4+ T helper cell function in association with autoimmunity.

Authors:  C S Via; G M Shearer
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis.

Authors:  R Watanabe; H Wege; V ter Meulen
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.